Designation of Macrocyclic Sulfazan and Triazan as Innovated Compounds with Their Estimation in Nano-Activities by the Scanning Microscope

Abstract

Sulfazan and Triazan Compounds were created for the first time as a class of organic chemistry in 2019 globally for the first time, then developed by researcher Dr. Nagham Aljamali in April 2021, while same researcher created and invented Sulfazan compounds as a nano-compounds, anti-bio compounds .,and since the references are few on Sulfazan, so we have prepared a many of them and studied their applications in various fields to enrich this topic with references. A numeral of practical spectroscopic studies have been used to exhibit their chemical structures which provided strong evidences of their chemical structures through various technical devices like (FT IR-Spectra, 1H.NMR-Spectra, Mass-Spectra)., Melting points, other studies exemplified by evolution them as a Nano-compounds by Scanning Electron Microscopy (FESEM).

Pyrimidine-Sulphone Ligands (Formation, Characterization, Bio Evaluation) as Bio-Compounds

“…Nowadays there are increasing numbers of infections caused by bacteria that are resistant to most of the antibacterial treatments currently available. In some experiments conducted on mice, results were given that the association of pyrimidine [16][17][18][19][20] with some compounds used as chemotherapy for tumors improves its effectiveness and reduces the spread of the tumor as well as reduces the toxic effects that result from the chemotherapy itself. In reducing the spread of breast cancer in mice., The pyrimidine substitutes have similar efficacy to the pharmaceutical-pharmaceutical compounds [21][22][23][24][25][26][27] used in the treatment of ulcers and infections, nerve paralysis, ulcers, and they are also used as lipid oxidation inhibitors in experiments conducted on rats.…”